Poly(Cyclohexene Phthalate) Nanoparticles for Controlled Dasatinib Delivery in Breast Cancer Therapy

The effect on the activity in breast cancer models of the small tyrosine kinase inhibitor dasatinib (DAS), either alone or in combination with other antitumoral agents, has been recently explored. However, DAS is characterized by its low and highly pH-dependent solubility, which could lead to poor u...

Descripción completa

Detalles Bibliográficos
Autores principales: Niza, Enrique, Nieto-Jiménez, Cristina, Noblejas-López, María del Mar, Bravo, Iván, Castro-Osma, José Antonio, de la Cruz-Martínez, Felipe, Martínez de Sarasa Buchaca, Marc, Posadas, Inmaculada, Canales-Vázquez, Jesús, Lara-Sanchez, Agustín, Hermida-Merino, Daniel, Solano, Eduardo, Ocaña, Alberto, Alonso-Moreno, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780527/
https://www.ncbi.nlm.nih.gov/pubmed/31461998
http://dx.doi.org/10.3390/nano9091208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780527/
https://www.ncbi.nlm.nih.gov/pubmed/31461998
http://dx.doi.org/10.3390/nano9091208

Ejemplares similares